Difficult-to-Treat and Severe Asthma: Management Strategies - American Family Physician
Mar 1, 2021 - Asthma is a common chronic inflammatory disease in the United States. Up to 17% of asthma cases are classified as difficult to treat, and 3.7% of these are considered severe. Uncontrolled asthma is characterized by poor symptom control or frequent exacerbations. In difficult-to-treat ...
American Family Physician : Article
https://www.aafp.org/afp/2021/0301/p286.html
Asthma - American Family Physician
Feb 15, 2021 - This collection features AFP content on asthma and related issues, including allergens, beta agonists, chronic cough, exercise-induced bronchoconstriction, inhalers, and wheezing. This collection features AFP content on asthma and related issues, including allergens, beta agonists, ...
- Overview
- Screening and Diagnosis
- Prevention
- Treatment
- Complications and Special Situations
- Editorials and Letters
- Improving Practice
- Patient Education, Self-Care
- Other AFP Content
- Other Resources from AAFP
American Family Physician : AFP By Topic
https://www.aafp.org/afp/topicModules/viewTopicModule.htm?topicModuleId=3
Intravenous Magnesium Sulfate for Acute Asthma Exacerbation in Children and Adults - ...
Feb 15, 2021 - Patients who received intravenous magnesium sulfate for acute asthma exacerbation in the emergency department had decreased hospital admissions and no serious adverse effects.
American Family Physician : Medicine by the Numbers
https://www.aafp.org/afp/2021/0215/p245.html
Effects of Inhaled Corticosteroids on Growth in Children with Persistent Asthma - ...
Oct 1, 2020 - Inhaled fluticasone (Flovent; 200 mcg per day) is associated with a greater linear growth velocity when compared with beclomethasone (400 mcg per day; an equivalent dose).
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2020/1001/p404.html
navigate_before 1 navigate_next